A detailed history of Jump Financial, LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Jump Financial, LLC holds 53,561 shares of AXGN stock, worth $789,489. This represents 0.02% of its overall portfolio holdings.

Number of Shares
53,561
Holding current value
$789,489
% of portfolio
0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.52 - $14.69 $402,778 - $786,811
53,561 New
53,561 $750,000
Q4 2022

Feb 13, 2023

SELL
$9.44 - $13.09 $85,894 - $119,105
-9,099 Reduced 32.97%
18,500 $184,000
Q3 2022

Nov 07, 2022

BUY
$8.14 - $12.25 $224,655 - $338,087
27,599 New
27,599 $329,000
Q2 2022

Aug 09, 2022

SELL
$6.99 - $10.0 $144,693 - $207,000
-20,700 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$7.26 - $10.7 $131,406 - $193,670
-18,100 Reduced 46.65%
20,700 $164,000
Q4 2021

Feb 10, 2022

BUY
$8.8 - $16.0 $341,440 - $620,800
38,800 New
38,800 $364,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $623M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.